FR, A., Z, K., H, M., A, G., AM, A., MM, R., & MA, S. (2024). Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement. Current problems in cardiology, 49(5), 102524. https://doi.org/10.1016/j.cpcardiol.2024.102524
Chicago Style (17th ed.) CitationFR, Alsereidi, Khashim Z, Marzook H, Gupta A, Al-Rawi AM, Ramadan MM, and Saleh MA. "Targeting Inflammatory Signaling Pathways with SGLT2 Inhibitors: Insights into Cardiovascular Health and Cardiac Cell Improvement." Current Problems in Cardiology 49, no. 5 (2024): 102524. https://doi.org/10.1016/j.cpcardiol.2024.102524.
MLA (9th ed.) CitationFR, Alsereidi, et al. "Targeting Inflammatory Signaling Pathways with SGLT2 Inhibitors: Insights into Cardiovascular Health and Cardiac Cell Improvement." Current Problems in Cardiology, vol. 49, no. 5, 2024, p. 102524, https://doi.org/10.1016/j.cpcardiol.2024.102524.